JW Pharmaceutical Corporation
KRX:001060.KS
27,350 (KRW) • At close September 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | JW Pharmaceutical Corporation |
Symbool | 001060.KS |
Munteenheid | KRW |
Prijs | 27,350 |
Beurswaarde | 628,696,884,150 |
Dividendpercentage | 1.32% |
52-weken bereik | 24,068.6 - 39,902 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Young-Sub Shin |
Website | https://www.jw-pharma.co.kr |
An error occurred while fetching data.
Over JW Pharmaceutical Corporation
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)